Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Torsades de Pointes | 4 | 2023 | 78 | 2.380 |
Why?
|
| Long QT Syndrome | 4 | 2023 | 453 | 1.750 |
Why?
|
| Anti-Arrhythmia Agents | 8 | 2023 | 790 | 1.590 |
Why?
|
| Potassium Compounds | 2 | 2019 | 40 | 1.270 |
Why?
|
| Ventricular Fibrillation | 3 | 2019 | 538 | 1.240 |
Why?
|
| Tachycardia | 3 | 2015 | 620 | 1.010 |
Why?
|
| Electrocardiography | 13 | 2023 | 6440 | 0.950 |
Why?
|
| Emergency Service, Hospital | 16 | 2018 | 7645 | 0.940 |
Why?
|
| Emergency Medicine | 5 | 2022 | 1205 | 0.870 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2016 | 1016 | 0.870 |
Why?
|
| Ventricular Premature Complexes | 1 | 2023 | 111 | 0.830 |
Why?
|
| Confidence Intervals | 2 | 2020 | 2970 | 0.820 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2020 | 783 | 0.820 |
Why?
|
| Likelihood Functions | 4 | 2015 | 1003 | 0.790 |
Why?
|
| Heart Massage | 1 | 2019 | 30 | 0.720 |
Why?
|
| Procainamide | 2 | 2010 | 61 | 0.710 |
Why?
|
| Calcium Compounds | 1 | 2019 | 34 | 0.710 |
Why?
|
| Tachycardia, Ventricular | 4 | 2012 | 1272 | 0.650 |
Why?
|
| Coronary Occlusion | 1 | 2021 | 303 | 0.630 |
Why?
|
| Heart Arrest, Induced | 1 | 2019 | 355 | 0.620 |
Why?
|
| Headache | 2 | 2016 | 1219 | 0.610 |
Why?
|
| Calcium Chloride | 1 | 2016 | 77 | 0.560 |
Why?
|
| Droperidol | 1 | 2016 | 21 | 0.560 |
Why?
|
| Amiodarone | 2 | 2010 | 212 | 0.560 |
Why?
|
| Heart Arrest | 5 | 2019 | 1469 | 0.550 |
Why?
|
| Dangerous Behavior | 1 | 2016 | 66 | 0.540 |
Why?
|
| Hypokalemia | 1 | 2017 | 153 | 0.540 |
Why?
|
| Resuscitation | 2 | 2019 | 657 | 0.510 |
Why?
|
| Narcotics | 1 | 2017 | 343 | 0.500 |
Why?
|
| Methadone | 1 | 2017 | 306 | 0.490 |
Why?
|
| Spinal Puncture | 2 | 2014 | 281 | 0.490 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 974 | 0.410 |
Why?
|
| Hypothermia, Induced | 2 | 2016 | 747 | 0.400 |
Why?
|
| Pneumothorax | 1 | 2015 | 379 | 0.390 |
Why?
|
| Conscious Sedation | 1 | 2016 | 528 | 0.390 |
Why?
|
| Atrial Flutter | 1 | 2013 | 264 | 0.380 |
Why?
|
| Biometry | 2 | 2004 | 558 | 0.370 |
Why?
|
| Hypotension | 5 | 2021 | 880 | 0.370 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2012 | 425 | 0.360 |
Why?
|
| Heart Conduction System | 1 | 2015 | 1048 | 0.350 |
Why?
|
| Pulmonary Emphysema | 1 | 2015 | 672 | 0.340 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 532 | 0.340 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 1285 | 0.320 |
Why?
|
| Heart Rate | 3 | 2023 | 4091 | 0.320 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2015 | 2267 | 0.320 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 1914 | 0.310 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1158 | 0.310 |
Why?
|
| Hyperbilirubinemia | 1 | 2007 | 77 | 0.290 |
Why?
|
| Linear Models | 4 | 2014 | 5948 | 0.290 |
Why?
|
| Nitrites | 1 | 2007 | 160 | 0.280 |
Why?
|
| Atrial Fibrillation | 3 | 2023 | 5019 | 0.270 |
Why?
|
| Emergency Treatment | 1 | 2010 | 517 | 0.270 |
Why?
|
| Sepsis | 2 | 2021 | 2589 | 0.270 |
Why?
|
| Adenosine | 1 | 2009 | 823 | 0.240 |
Why?
|
| Swine | 3 | 2019 | 5934 | 0.240 |
Why?
|
| Bundle-Branch Block | 1 | 2005 | 270 | 0.230 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 14720 | 0.230 |
Why?
|
| Random Allocation | 2 | 2019 | 2425 | 0.220 |
Why?
|
| Optic Nerve | 3 | 2013 | 548 | 0.220 |
Why?
|
| Aortic Diseases | 1 | 2008 | 741 | 0.200 |
Why?
|
| Sotalol | 1 | 2001 | 49 | 0.190 |
Why?
|
| Dimenhydrinate | 1 | 2000 | 6 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 786 | 0.190 |
Why?
|
| GABA Modulators | 1 | 2000 | 107 | 0.180 |
Why?
|
| Histamine H1 Antagonists | 1 | 2000 | 100 | 0.180 |
Why?
|
| Lorazepam | 1 | 2000 | 145 | 0.180 |
Why?
|
| Infusions, Intravenous | 4 | 2010 | 2271 | 0.180 |
Why?
|
| Humans | 47 | 2023 | 742088 | 0.180 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2303 | 0.180 |
Why?
|
| Chest Pain | 3 | 2015 | 1113 | 0.180 |
Why?
|
| Anticoagulants | 2 | 2023 | 4595 | 0.170 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1999 | 73 | 0.170 |
Why?
|
| Vertigo | 1 | 2000 | 201 | 0.170 |
Why?
|
| Retrospective Studies | 12 | 2023 | 77098 | 0.160 |
Why?
|
| Intracranial Hypertension | 2 | 2013 | 186 | 0.160 |
Why?
|
| Ultrasonography | 6 | 2021 | 5978 | 0.160 |
Why?
|
| Disease Progression | 1 | 2015 | 13256 | 0.160 |
Why?
|
| Emergency Nursing | 1 | 2018 | 45 | 0.160 |
Why?
|
| Diagnosis, Differential | 5 | 2015 | 12958 | 0.160 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2007 | 1204 | 0.150 |
Why?
|
| Pregnancy, Ectopic | 1 | 1999 | 141 | 0.150 |
Why?
|
| Fluid Therapy | 1 | 2021 | 592 | 0.150 |
Why?
|
| Sample Size | 2 | 2015 | 844 | 0.150 |
Why?
|
| Hospital Charges | 1 | 1999 | 362 | 0.150 |
Why?
|
| Carotid Arteries | 1 | 2021 | 952 | 0.140 |
Why?
|
| Learning Curve | 1 | 2018 | 200 | 0.140 |
Why?
|
| Middle Aged | 21 | 2021 | 213127 | 0.140 |
Why?
|
| Thermography | 1 | 2016 | 67 | 0.140 |
Why?
|
| Time | 1 | 2017 | 530 | 0.140 |
Why?
|
| Female | 25 | 2021 | 379592 | 0.130 |
Why?
|
| Binomial Distribution | 1 | 2015 | 25 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 9639 | 0.130 |
Why?
|
| Case-Control Studies | 2 | 2023 | 21719 | 0.130 |
Why?
|
| Body Temperature Regulation | 1 | 2016 | 252 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 12242 | 0.120 |
Why?
|
| Syndrome | 2 | 2015 | 3248 | 0.120 |
Why?
|
| Lidocaine | 1 | 1997 | 542 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 344 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2016 | 437 | 0.120 |
Why?
|
| Male | 23 | 2021 | 349538 | 0.120 |
Why?
|
| Dyspnea | 2 | 2015 | 1298 | 0.120 |
Why?
|
| Brugada Syndrome | 1 | 2015 | 97 | 0.120 |
Why?
|
| Intracranial Pressure | 2 | 2013 | 326 | 0.110 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2014 | 117 | 0.110 |
Why?
|
| Least-Squares Analysis | 2 | 2004 | 379 | 0.110 |
Why?
|
| Erythrocyte Count | 1 | 2013 | 163 | 0.110 |
Why?
|
| Coma | 1 | 2016 | 475 | 0.110 |
Why?
|
| Point-of-Care Systems | 2 | 2013 | 1175 | 0.100 |
Why?
|
| ROC Curve | 2 | 2012 | 3528 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20086 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 1254 | 0.090 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 15056 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 1483 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2022 | 9846 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2021 | 3801 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2010 | 1589 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18006 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2013 | 1653 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 1737 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 1342 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2015 | 773 | 0.080 |
Why?
|
| Nurses | 1 | 2018 | 2459 | 0.080 |
Why?
|
| Prognosis | 2 | 2022 | 29010 | 0.080 |
Why?
|
| Atrioventricular Node | 1 | 2009 | 182 | 0.080 |
Why?
|
| Aged | 12 | 2021 | 162944 | 0.080 |
Why?
|
| Heart | 1 | 2021 | 4462 | 0.080 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 499 | 0.080 |
Why?
|
| Electric Countershock | 2 | 2014 | 535 | 0.080 |
Why?
|
| Pulmonary Embolism | 2 | 2012 | 2370 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 19862 | 0.080 |
Why?
|
| New York | 1 | 2010 | 886 | 0.070 |
Why?
|
| Logistic Models | 2 | 2012 | 13403 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2337 | 0.060 |
Why?
|
| Length of Stay | 2 | 2015 | 6294 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1155 | 0.060 |
Why?
|
| Teaching Materials | 1 | 2004 | 86 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2004 | 6452 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2005 | 349 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2005 | 262 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 643 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 2 | 2004 | 2714 | 0.060 |
Why?
|
| Hospitalization | 3 | 2023 | 10232 | 0.060 |
Why?
|
| Normal Distribution | 1 | 2004 | 280 | 0.060 |
Why?
|
| Oxygen | 1 | 2015 | 4169 | 0.060 |
Why?
|
| Valproic Acid | 1 | 2005 | 446 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2005 | 880 | 0.050 |
Why?
|
| Animals | 4 | 2019 | 168561 | 0.050 |
Why?
|
| Syncope | 1 | 2005 | 429 | 0.050 |
Why?
|
| Clinical Competence | 4 | 2018 | 4681 | 0.050 |
Why?
|
| Critical Care | 1 | 2015 | 2640 | 0.050 |
Why?
|
| Adult | 10 | 2014 | 213712 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4929 | 0.050 |
Why?
|
| Computer Graphics | 1 | 2004 | 360 | 0.050 |
Why?
|
| Risk | 1 | 2014 | 9679 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2017 | 40450 | 0.050 |
Why?
|
| Sex Factors | 1 | 2015 | 10392 | 0.050 |
Why?
|
| Time Factors | 4 | 2016 | 40054 | 0.050 |
Why?
|
| Software | 1 | 2015 | 4434 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3391 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1849 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 1573 | 0.050 |
Why?
|
| Acute Disease | 2 | 2008 | 7141 | 0.050 |
Why?
|
| Risk Factors | 4 | 2017 | 72145 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3215 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2021 | 62966 | 0.040 |
Why?
|
| Prospective Studies | 8 | 2021 | 53187 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 13853 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 1999 | 149 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2001 | 389 | 0.040 |
Why?
|
| Insurance Claim Reporting | 1 | 1999 | 163 | 0.040 |
Why?
|
| American Heart Association | 1 | 2023 | 1055 | 0.040 |
Why?
|
| Texas | 1 | 1999 | 392 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 1525 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2170 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 1423 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 5979 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2005 | 1541 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2009 | 4567 | 0.040 |
Why?
|
| Massachusetts | 1 | 2010 | 8662 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5095 | 0.030 |
Why?
|
| Rewarming | 1 | 2016 | 61 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1420 | 0.030 |
Why?
|
| Decision Making | 1 | 2009 | 3869 | 0.030 |
Why?
|
| Heart Failure | 3 | 2009 | 10856 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2018 | 2485 | 0.030 |
Why?
|
| Education | 1 | 2018 | 543 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2016 | 613 | 0.030 |
Why?
|
| Curriculum | 1 | 2007 | 3589 | 0.030 |
Why?
|
| Reference Values | 2 | 2013 | 4982 | 0.030 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 2400 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8621 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10943 | 0.030 |
Why?
|
| Walking | 1 | 2000 | 1177 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 3913 | 0.030 |
Why?
|
| Documentation | 1 | 1999 | 865 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7276 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39004 | 0.030 |
Why?
|
| Triage | 1 | 1999 | 977 | 0.030 |
Why?
|
| Echocardiography | 1 | 2004 | 5097 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57683 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2000 | 3418 | 0.020 |
Why?
|
| Sleep | 1 | 2005 | 4604 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 26343 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2008 | 116 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2007 | 5774 | 0.020 |
Why?
|
| Blood | 1 | 1990 | 598 | 0.020 |
Why?
|
| Models, Biological | 1 | 2004 | 9581 | 0.020 |
Why?
|
| Perception | 1 | 2013 | 1188 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2008 | 136 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12017 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 35342 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1999 | 3839 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 1990 | 1126 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2266 | 0.010 |
Why?
|
| Observer Variation | 1 | 2009 | 2593 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 834 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 2009 | 11690 | 0.010 |
Why?
|
| Dissection | 1 | 2004 | 294 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 1129 | 0.010 |
Why?
|
| Intracranial Hemorrhages | 1 | 2008 | 854 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 29717 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2007 | 1206 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 24913 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2451 | 0.010 |
Why?
|
| Urban Population | 1 | 2008 | 2018 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1990 | 3760 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5062 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2014 | 8541 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3923 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 7716 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 29087 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 2749 | 0.010 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2001 | 609 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3038 | 0.010 |
Why?
|
| Mathematics | 1 | 1990 | 727 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 23320 | 0.000 |
Why?
|
| Magnetics | 1 | 1990 | 609 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 85649 | 0.000 |
Why?
|
| United States | 1 | 2007 | 69693 | 0.000 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_